| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80860206P | 2006-05-26 | 2006-05-26 |
| Publication Number | Publication Date |
|---|---|
| ZA200809956Btrue ZA200809956B (en) | 2010-07-28 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200809956AZA200809956B (en) | 2006-05-26 | 2007-05-24 | Methods and compositions using Immunomodulatory compounds in combination therapy |
| Country | Link |
|---|---|
| EP (1) | EP2023912A2 (en) |
| JP (1) | JP2009538318A (en) |
| KR (1) | KR20090014393A (en) |
| CN (1) | CN101495111A (en) |
| AU (1) | AU2007267928A1 (en) |
| CA (1) | CA2652888A1 (en) |
| IL (1) | IL195412A0 (en) |
| MX (1) | MX2008014912A (en) |
| RU (1) | RU2426542C2 (en) |
| WO (1) | WO2007139939A2 (en) |
| ZA (1) | ZA200809956B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2249835A1 (en)* | 2008-01-29 | 2010-11-17 | Celgene Corporation | Methods using immunomodulatory compounds for modulating level of cd59 |
| CA2868302A1 (en)* | 2012-03-23 | 2013-09-26 | Dennis M. Brown | Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
| KR20160033779A (en) | 2013-08-22 | 2016-03-28 | 반다 파마슈티칼즈, 인코퍼레이티드. | Cancer treatment |
| MX386151B (en)* | 2013-08-22 | 2025-03-18 | Vanda Pharmaceuticals Inc | USE OF TRICHOSTATIN A (TSA) IN THE TREATMENT OF MULTIPLE MYELOMA. |
| EP3122181A4 (en)* | 2014-03-26 | 2018-04-25 | The Brigham and Women's Hospital, Inc. | Compositions and methods for ex vivo expansion of human hematopoietic stem/progenitor cells |
| WO2015175916A1 (en)* | 2014-05-16 | 2015-11-19 | Celgene Corporation | Methods and compositions using 4-amino-2-(2,6 dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment of cancers |
| WO2023034504A1 (en)* | 2021-09-01 | 2023-03-09 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for inducing fetal hemoglobin, modulating erythroid cell lineages, and perturbing megakaryocyte lineages |
| TW202434562A (en)* | 2022-11-04 | 2024-09-01 | 美商必治妥美雅史谷比公司 | Compounds and their use for treatment of hemoglobinopathies |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629327A (en)* | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
| US7498171B2 (en)* | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| ES2521672T3 (en)* | 2002-05-17 | 2014-11-13 | Celgene Corporation | Pharmaceutical formulations for cancer treatment |
| BR0315609A (en)* | 2002-10-24 | 2005-08-23 | Celgene Corp | Method of treating, preventing, modifying or controlling pain and pharmaceutical composition |
| US7563810B2 (en)* | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
| US20050043233A1 (en)* | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
| ZA200604815B (en)* | 2003-12-02 | 2007-10-31 | Celgene Corp | Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
| US20060058311A1 (en)* | 2004-08-14 | 2006-03-16 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation |
| Publication number | Publication date |
|---|---|
| RU2008151713A (en) | 2010-07-10 |
| CA2652888A1 (en) | 2007-12-06 |
| WO2007139939A3 (en) | 2008-07-03 |
| AU2007267928A1 (en) | 2007-12-06 |
| KR20090014393A (en) | 2009-02-10 |
| MX2008014912A (en) | 2008-12-10 |
| RU2426542C2 (en) | 2011-08-20 |
| JP2009538318A (en) | 2009-11-05 |
| WO2007139939A2 (en) | 2007-12-06 |
| EP2023912A2 (en) | 2009-02-18 |
| IL195412A0 (en) | 2009-08-03 |
| CN101495111A (en) | 2009-07-29 |
| Publication | Publication Date | Title |
|---|---|---|
| IL191072A0 (en) | Therapeutic compositions and methods | |
| EP2180873A4 (en) | Therapeutic dental composition and related methods | |
| EP2182922A4 (en) | Antigen-adjuvant compositions and methods | |
| EP2035014A4 (en) | Fucoidan compositions and methods | |
| ZA201203709B (en) | Immunogenic compositions and methods | |
| PT1899364T (en) | Compositions and methods for immunomodulation in an organism | |
| EP1895838A4 (en) | Compositions and methods | |
| IL195619A0 (en) | Compositions and methods for joininig non-conjoined iumens | |
| PL2705826T3 (en) | Fluoride composition and methods for dental mineralization | |
| EP2101731A4 (en) | Endoxifen methods and compositions | |
| EP1984015A4 (en) | Methods and compositions for treating asthma in human and non human primates | |
| IL198723A0 (en) | Methods and compositions for therapeutic treatment | |
| GB0721291D0 (en) | Methods and compositions | |
| IL247957A0 (en) | Anti-ephrinb2 antibofies and methods using same | |
| EP2083755A4 (en) | Medical kit and using method thereof | |
| IL194826A0 (en) | Compositions and methods for cellular imaging and therapy | |
| IL195412A0 (en) | Methods and compositions using immunomodulatory compounds in combination therapy | |
| GB0617171D0 (en) | Novel compositions and methods | |
| PL2012805T3 (en) | Therapeutic composition and use | |
| IL196411A0 (en) | Anti-cocaine compositions and treatment | |
| GB0719526D0 (en) | Compositions and methods | |
| EP2097085A4 (en) | Therapeutic materials and methods | |
| GB0714500D0 (en) | composition and treatment | |
| GB0501348D0 (en) | Compositions and methods | |
| GB0517546D0 (en) | Therapeutic methods and compositions |